Skip to main content
SpringerLink
Log in

Participation in Recreational Sports for Young Patients with Genetic Cardiovascular Diseases

  • Chapter
  • First Online:
Book cover Clinical Approach to Sudden Cardiac Death Syndromes

  • 1208 Accesses

Abstract

Genetic cardiovascular diseases (GCVDs) include hypertrophic cardiomyopathy (HCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), Marfan syndrome, and the ion-channel diseases, i.e., long-QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT).1-16 Although relatively uncommon in the general population and most cardiology practices, these conditions are nevertheless frequently associated with an increased risk of sudden death during exercise, events which are devastating to the families, community, and physicians, particularly in light of the youthful age of the victims. GCVDs account for a substantial proportion of the unexpected and usually arrhythmic, fatal events occurring during adolescence and young adulthood.1-27

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Maron BJ, Moller JH, Seidman CE, et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome: a statement for healthcare professionals from the councils on clinical cardiology, cardiovascular disease in the young, and basic science, American Heart Association. Circulation. 1998;98:1460-1471

    CAS  Google Scholar 

  2. Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol. 2008;19:104-110

    PubMed  Google Scholar 

  3. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348: 1866-1874

    Article  PubMed  Google Scholar 

  4. Priori SG, Barhanin J, Hauer RN, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management, parts I and II. Circulation. 1999;99:518-528

    CAS  PubMed  Google Scholar 

  5. Vincent GM, Timothy KW, Leppert M, et al. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med. 1992;327:846-852

    Article  CAS  PubMed  Google Scholar 

  6. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129-133

    Article  CAS  PubMed  Google Scholar 

  7. Antzelevitch C, Brugada P, Brugada J, et al. Brugada syndrome: 1992-2002: a historical perspective. J Am Coll Cardiol. 2003;41:1665-1671

    Article  PubMed  Google Scholar 

  8. Towbin JA. Molecular genetic basis of sudden cardiac death. Cardiovasc Pathol. 2001;10:283-295

    Article  CAS  PubMed  Google Scholar 

  9. Rampazzo A, Nava A, Malacrida S, et al. Mutation in human desmoplakin domain binding to plakoglobin causes adominant form of arrhythmogenic Right ventricular cardiomyopathy. Am J Hum Genet. 2002;71:1200-1206

    Article  CAS  PubMed  Google Scholar 

  10. Tiso N, Stephan DA, Nava A, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic Right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 2001;10:189-194

    Article  CAS  PubMed  Google Scholar 

  11. Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337-339

    Article  CAS  PubMed  Google Scholar 

  12. Dietz HC, Pyritz RE. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet. 1995;4:1799-1809

    CAS  PubMed  Google Scholar 

  13. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 1995;91:1512-1519

    Google Scholar 

  14. Ackerman MJ, Clapham DE. Ion channels: basic science and clinical disease. N Engl J Med. 1997;336:1575-1586

    Article  CAS  PubMed  Google Scholar 

  15. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002; 106:69-74

    Article  CAS  PubMed  Google Scholar 

  16. Myerburg RJ. Scientific gaps in the prediction and prevention of sudden cardiac death. J Cardiovasc Electrophysiol. 2002;13:709-723

    Article  PubMed  Google Scholar 

  17. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes: clinical, demographic and pathologic profiles. JAMA. 1996;276:199-204

    Article  CAS  PubMed  Google Scholar 

  18. Yetman AT, Bornemeier RA, McCrindle BW. Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of Sudden death? J Am Coll Cardiol. 2003;41:329-332

    Google Scholar 

  19. Maron BJ, Carney KP, Lever HM, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003;41:974-980

    Article  PubMed  Google Scholar 

  20. VanCamp SP, Bloor CM, Mueller FO, et al. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc. 1995;27:641-647

    CAS  Google Scholar 

  21. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med. 1996;334:1039-1044

    Google Scholar 

  22. Burke AP, Farb A, Virmani R, et al. Sports-related and non-sports-related sudden cardiac death in young adults. Am Heart J. 1991;121(pt1):568-575

    Google Scholar 

  23. Maron BJ. Cardiovascular risks to young persons on the athletic field. Ann Intern Med. 1998;129:379-386

    CAS  PubMed  Google Scholar 

  24. Corrado D, Thiene G, Nava A, et al. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med. 1990;89:588-596

    Article  CAS  PubMed  Google Scholar 

  25. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003;349:1064-1075

    Article  CAS  PubMed  Google Scholar 

  26. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308-1320

    Article  PubMed  Google Scholar 

  27. Estes NA, Link MS, Cannom D, et al. Report of the NASPE Policy conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol. 2001;12:1208-1219

    Article  PubMed  Google Scholar 

  28. Mitchell JH, Maron BJ, Epstein SE.16th Bethesda conference: cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. J Am Coll Cardiol. 1985;6:1186-1232

    Google Scholar 

  29. Maron BJ, Mitchell JH. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol. 1994;24:845-899

    Article  Google Scholar 

  30. Maron JB, Zipes DP. 36th Bethesda conference. Eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2005;45:1313-1368

    Google Scholar 

  31. Pelliccia A, Zipes DP, Maron BJ. Bethesda conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2008;52:1990-1996

    Google Scholar 

  32. Balady GJ, Chaitman B, Driscoll D, et al. Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities. Circulation. 1998;97:2283-2293

    CAS  PubMed  Google Scholar 

  33. Albert CM, Mittleman MA, Chae CU, et al. Triggering of sudden death by vigorous exertion. N Engl J Med. 2000;343: 1355-1361

    Article  CAS  PubMed  Google Scholar 

  34. Maron BJ, Araújo CG, Thompson PD, Fletcher GF, de Luna AB, Fleg JL, Pelliccia A, Balady GJ, Furlanello F, Van Camp SP, Elosua R, Chaitman BR, Bazzarre TL; World Heart Federation; International Federation of Sports Medicine; American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention. Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes: an advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation. 2001;103:327-334

    Google Scholar 

  35. Maron BJ, Chaitman BR, Ackerman MJ, Bayés de Luna A, Corrado D, Crosson JE, Deal BJ, Driscoll DJ, Estes NAM III, Araújo CG, Liang DH, Mitten MJ, Myerburg RJ, Pelliccia A, Thompson PD, Towbin JA, Van Camp SP. American Heart Association Scientific Statement: Recommendations for Physical Activity and Recreational Sports Participation for Young Patients with Genetic Cardiovascular Diseases. Circulation. 2004;109:2807-2816

    Google Scholar 

  36. Basso C, Thiene G, Corrado D, et al. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol. 2000;31: 988-998

    Article  CAS  PubMed  Google Scholar 

  37. Corrado D, Basso C, Thiene G, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol. 1997;30:1512-1520

    Article  CAS  PubMed  Google Scholar 

  38. Pyeritz RE. The Marfan syndrome. Annu Rev Med. 2000; 51:481-510

    Google Scholar 

  39. Matsuo K, Kurita T, Inagaki M, et al. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J. 1999;20:465-470

    Article  CAS  PubMed  Google Scholar 

  40. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1,866 deaths in the U.S., 1980-2006. Circulation. 119:1085-1092

    Google Scholar 

  41. Basso C, Maron BJ, Corrado D, et al. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol. 2000;35:1493-1501

    Article  CAS  PubMed  Google Scholar 

  42. Corrado D, Basso C, Poletti A, Angelini A, Valente M, Thiene G. Sudden death in the young. Is acute coronary thrombosis the major precipitating factor? Circulation. 1994;90:2315-2323

    Google Scholar 

  43. Fletcher GF, Blair SN, Blumenthal J, Caspersen C, Chaitman B, Epstein S, Falls H, Froelicher ES, Froelicher VF, Pina IL. Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart association. Circulation. 1992;86:340-344

    Google Scholar 

  44. NIH Consensus Development Panel on Physical Activity and Cardiovascular Health. Physical activity and cardiovascular health. JAMA. 1996;276:241-246

    Article  Google Scholar 

  45. Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev Nutr. 2001;21:323-341

    Article  CAS  PubMed  Google Scholar 

  46. Maron BJ. The paradox of exercise. N Engl J Med. 2000; 343:1409-1411

    Article  CAS  PubMed  Google Scholar 

  47. Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, Clark LT, Mitten MJ, Crawford MH, Atkins DL, Driscoll DJ, Epstein AE. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation. 1996;94:850-856

    Google Scholar 

  48. Corrado D, Basso C, Schiavon M, et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339:364-369

    Article  CAS  PubMed  Google Scholar 

  49. Maron BJ, Spirito P, Shen W-K, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298:405-412

    Article  CAS  PubMed  Google Scholar 

  50. Chatrath R, Porter CB, Ackerman MJ. Role of transvenous implantable cardioverter defibrillators in preventing sudden cardiac death in children, adolescents, and young adults. Mayo Clin Proc. 2002;77:226-231

    Article  PubMed  Google Scholar 

  51. Corrado D, Leoni L, Link MS, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084-3091

    Article  PubMed  Google Scholar 

  52. Moss AJ, Daubert JP. Images in clinical medicine: internal ventricular defibrillation. N Engl J Med. 2000;342:398

    Article  CAS  PubMed  Google Scholar 

  53. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2003;42:1687-1713 and Eur Heart J. 2003;24:1965-1991

    Google Scholar 

  54. Maron BJ, Niimura H, Casey SA, et al. Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C mutations. J Am Coll Cardiol. 2001;38:315-321

    Article  CAS  PubMed  Google Scholar 

  55. Maron BJ, Spirito P, Wesley YE, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med. 1986;315:610-614

    Article  CAS  PubMed  Google Scholar 

  56. Dumaine R, Towbin JA, Brugada P, et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res. 1999;85:803-809

    CAS  PubMed  Google Scholar 

  57. Kinoshita N, Mimura J, Obayashi C, et al. Aortic root dilatation among young competitive athletes: echocardiographic screening of 1929 athletes between 15 and 34 years of age. Am Heart J. 2000;139:723-728

    Article  CAS  PubMed  Google Scholar 

  58. Lange RA, Hillis LD. Cardiovascular complications of cocaine use [published erratum appears in N Engl J Med 2001;345:1432]. N Engl J Med.. 2001;345:351-358

    Article  CAS  PubMed  Google Scholar 

  59. Samenuk D, Link MS, Homoud MK, et al. Adverse cardiovascular events temporally associated with mahuang, an herbal source of ephedrine [published erratum appears in Mayo Clin Proc 2003;78:1055]. Mayo Clin Proc. 2002;77:12-16

    Article  PubMed  Google Scholar 

  60. Valli G, Giardina EG. Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. J Am Coll Cardiol. 2002;39:1083-1095

    Article  PubMed  Google Scholar 

  61. Shen W-K, Edwards WD, Hammill SC, et al. Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study. Am J Cardiol. 1995;76:148-152

    Article  CAS  PubMed  Google Scholar 

  62. Maron BJ, Zipes DP. Heart Rhythm Controversy: it is not prudent to allow all athletes with ICDs to participate in all sports (editorial). Heart Rhythm. 2008;5:864-866

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 E 28th Street, Suite 620, Minneapolis, MN, 55407, USA

    Barry J. Maron

Authors
  1. Barry J. Maron
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barry J. Maron .

Editor information

Editors and Affiliations

  1. Masonic Medical Research Laboratory, Bleecker St. 2150, Utica, 13501, U.S.A.

    Ramon Brugada

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London

About this chapter

Cite this chapter

Maron, B.J. (2010). Participation in Recreational Sports for Young Patients with Genetic Cardiovascular Diseases. In: Brugada, R. (eds) Clinical Approach to Sudden Cardiac Death Syndromes. Springer, London. https://doi.org/10.1007/978-1-84882-927-5_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-927-5_25

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-926-8

  • Online ISBN: 978-1-84882-927-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation